STOCK TITAN

Arxis (NASDAQ: ARXS) lifts 2026 guidance after strong Q2 growth

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Arxis, Inc. reported strong second quarter 2026 results, with revenue of $501 million, up 25% year-over-year, including 21% organic growth across Electronic and Mechanical Components. Demand was broad-based, led by Defense & Space, and favorable trends in Commercial Aerospace and Industrial Technology.

The company recorded a net loss of $4.9 million, improved from a $29.3 million loss, as stronger operations were offset by share-based compensation tied to its initial public offering. Adjusted EBITDA rose 38% to $211 million, and Adjusted EBITDA margin expanded 390 basis points to 42.2%, supported by volume growth, disciplined pricing, and productivity initiatives.

Cash generation was robust, with net cash from operating activities of $138 million and Free Cash Flow of $127 million, both sharply higher year-over-year. Arxis completed the MagCanica acquisition, agreed to acquire Omnetics, and closed the Blue Line acquisition. A term loan repricing is expected to save about $5 million of annual cash interest, helping reduce net leverage to 1.8x. Reflecting first-half performance and visibility backed by orders and acquisitions, Arxis raised full-year 2026 guidance to revenue of $1,960–$1,980 million and Adjusted EBITDA of $790–$800 million, implying an Adjusted EBITDA margin of approximately 40.4%.

Positive

  • Revenue grew 25% year-over-year to $501 million, with 21% organic growth and broad-based strength across key end markets.
  • Adjusted EBITDA increased 38% to $211 million, with margin expanding 390 bps to 42.2%, indicating improved operating efficiency.
  • Free Cash Flow rose 261% to $127 million, and net cash from operating activities nearly tripled, strengthening internal funding capacity.
  • Net leverage improved to 1.8x after debt reduction and a term loan repricing expected to save about $5 million of annual cash interest.
  • The company raised full-year 2026 guidance, lifting revenue by $100 million at the midpoint and Adjusted EBITDA by $70 million with higher margin expectations.

Negative

  • None.

Filing Explained

The post-IPO share structure affects ownership percentages; Blue Line closed, while Omnetics still needs approvals and closing.

This Form 8-K reports a specified material event—the unaudited second-quarter results—and records a post-reorganization and IPO share structure while the disclosed acquisitions are at different completion stages.

As of June 30, 2026, Class A had 77,712,735 shares issued and 76,797,587 outstanding, while Class B had 340,676,783 issued and outstanding; issuing additional shares increases the share count and can reduce an existing holder’s percentage ownership.

MagCanica was completed on June 1, 2026, and Blue Line was completed on July 29, 2026; the Omnetics agreement remains subject to regulatory approvals and other closing conditions, with closing expected during the third quarter.

For the six months ended June 30, 2026, the company reported $1,227,753 thousand of net proceeds from common-stock issuance; at quarter-end it reported $494,693 thousand of cash and $1,718,137 thousand of total debt.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Q2 2026 Revenue $501 million Three months ended June 30, 2026; up 25% year-over-year
Q2 2026 Net loss $(4.9) million Three months ended June 30, 2026; improved from $(29.3) million
Q2 2026 Adjusted EBITDA $211 million Three months ended June 30, 2026; up 38% with 42.2% margin
Q2 2026 Free Cash Flow $127 million Three months ended June 30, 2026; up 261% year-over-year
Net cash from operating activities $138 million Three months ended June 30, 2026; up 188% year-over-year
2026 Revenue Guidance $1,960 to $1,980 million Raised full-year 2026 revenue outlook; +$100 million at midpoint
2026 Adjusted EBITDA Guidance $790 to $800 million Raised full-year 2026 Adjusted EBITDA; +$70 million at midpoint
Net Leverage 1.8x Net debt to Adjusted EBITDA at June 30, 2026
Adjusted EBITDA financial
"Adjusted EBITDA(1) of $211 million, up 38%; Adjusted EBITDA margin(1)"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Free Cash Flow financial
"Net cash provided by operating activities of $138 million... Free Cash Flow(1) of $127 million"
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
Net Leverage financial
"Arxis ended the quarter with net leverage(1) of 1.8x, providing substantial capacity"
Net leverage measures how many years it would take for a company to pay off its outstanding debt using its annual operating cash flow, after subtracting cash on hand from total debt. Think of it like a household’s mortgage balance minus savings divided by yearly income; a lower number means the company is in a safer position to handle debt, while a higher number signals greater financial risk and potential pressure on profits or growth.
Tax Receivable Agreement financial
"Includes $13.3 million of expense related to the Convertible-Related Tax Receivable Agreement"
A contract in which a company agrees to pay a specified party (often former owners after a spinoff or IPO) a share of future tax savings the company realizes. Think of it like agreeing to share a future tax refund with someone who helped create the conditions for that refund. For investors it matters because those payments reduce the cash the company can use for dividends, buybacks, or reinvestment, and therefore affect valuation and returns.
non-GAAP financial measures financial
"This press release includes certain “non-GAAP financial measures,” which are financial measures"
Non-GAAP financial measures are numbers companies use to show their financial performance that exclude certain expenses or income. They help investors see how the company might perform without one-time costs or other unusual items, giving a different perspective from official reports. However, since they can be adjusted, they don’t always tell the full story and should be looked at alongside standard financial figures.
Revenue $501 million (Q2 2026) Up 25% year-over-year; 21% organic growth
Net income (loss) $(4.9) million (Q2 2026) Improved from $(29.3) million; net loss margin -1.0% vs -7.3%
Adjusted EBITDA $211 million (Q2 2026) Up 38%; margin expanded to 42.2% from 38.4%
Free Cash Flow $127 million (Q2 2026) Up 261% versus prior-year quarter
Net cash from operating activities $138 million (Q2 2026) Up 188% versus prior-year quarter
Net leverage 1.8x (June 30, 2026) Improved from 4.2x at December 31, 2025
Guidance

For full-year 2026, Arxis guides to revenue of $1,960 to $1,980 million, Adjusted EBITDA of $790 to $800 million, and Adjusted EBITDA margin of approximately 40.4%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How did Arxis (ARXS) perform financially in Q2 2026?

Arxis reported Q2 2026 revenue of $501 million, up 25% year-over-year, and a net loss of $4.9 million, improved from a $29.3 million loss, reflecting stronger operations but higher share-based compensation expense.

What were Arxis (ARXS) Q2 2026 non-GAAP results?

In Q2 2026, Arxis delivered Adjusted EBITDA of $211 million, up 38%, with Adjusted EBITDA margin of 42.2%. Adjusted Net Income was $113 million and Adjusted Diluted EPS was $0.28, highlighting improved underlying profitability.

Did Arxis (ARXS) raise its full-year 2026 guidance?

Yes. Arxis raised 2026 guidance to revenue of $1,960–$1,980 million from $1,860–$1,880 million and Adjusted EBITDA of $790–$800 million from $720–$730 million, targeting an Adjusted EBITDA margin of ~40.4%.

What was Arxis (ARXS) cash flow and leverage position after Q2 2026?

For the first half of 2026, Arxis generated $174.4 million of net cash from operating activities and $152.1 million of Free Cash Flow. At June 30, 2026, net leverage was 1.8x, with cash and equivalents of $494.7 million.

What acquisitions did Arxis (ARXS) complete around Q2 2026?

Arxis completed the MagCanica acquisition on June 1, 2026 and Blue Line Engineering on July 29, 2026. It also entered a definitive agreement to acquire Omnetics Connector Corporation, expected to close in the third quarter of 2026.

How did Arxis (ARXS) manage its debt and interest costs in Q2 2026?

Arxis repriced its term loan facility, which is expected to save about $5 million of annual cash interest. Total debt was $1.72 billion and cash $494.7 million, resulting in net leverage of 1.8x at June 30, 2026.
0002093536false00020935362026-07-292026-07-29

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 29, 2026

 

 

ARXIS, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-43234

39-5113483

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1332 Blue Hills Avenue

 

Bloomfield, Connecticut

 

06002

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 860 243-7100

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A common stock, par value $0.01 per share

 

ARXS

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

Item 2.02 Results of Operations and Financial Condition.

On July 29, 2026, Arxis, Inc. (the “Company”) issued a press release announcing its unaudited financial results for the second quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated by reference.

Information in Exhibit 99.1 of this Form 8-K shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise incorporated by reference into any filing pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.

Item 9.01 Financial Statements and Exhibits.

Exhibits.

 

 

 

 

  Exhibit No.

 

 99.1

Press Release Issued by Arxis, Inc. on July 29, 2026

 104

Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ARXIS, INC.

 

 

 

 

Date:

July 29, 2026

By:

/s/ Azad Badakhsh

 

 

 

Azad Badakhsh
Chief Financial Officer

 

 


Exhibit 99.1

img229377785_0.gif

 

Arxis Reports Second Quarter 2026 Results; Raises Full-Year 2026 Guidance

 

BLOOMFIELD, Conn., July 29, 2026 – Arxis, Inc. (NASDAQ: ARXS) (the “Company” or “Arxis”), a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical engineered components, today reported financial results for the second quarter ended June 30, 2026.

 

Second Quarter 2026 Highlights (all comparisons against the second quarter of 2025, unless otherwise noted):

·
Revenue of $501 million, up 25%
·
Net loss of $(5) million, compared to $(29) million; net loss margin of -1.0%, compared to -7.3%
·
Diluted loss per share of $(0.01)
·
Adjusted EBITDA(1) of $211 million, up 38%; Adjusted EBITDA margin(1) improved by 390 bps to 42.2%
·
Adjusted Net Income(1) of $113 million, up 726%
·
Adjusted Diluted Earnings Per Share(1) of $0.28
·
Net cash provided by operating activities of $138 million, up 188%; Free Cash Flow(1) of $127 million, up 261%

 

Raising Full-Year 2026 Guidance (all comparisons against prior guidance midpoint, unless otherwise noted):

·
Revenue range of $1,960 to $1,980 million, representing a 5% increase
·
Adjusted EBITDA(1) range of $790 to $800 million, representing a 10% increase
·
Adjusted EBITDA margin(1) of approximately 40.4%, an increase of 160 bps

 

“We continued to execute our disciplined, repeatable acquisition strategy during the quarter with the acquisition of MagCanica and the announced acquisition of Omnetics. Today, we also completed the acquisition of Blue Line Engineering, further expanding our portfolio of highly engineered, mission-critical businesses and strengthening our precision sensing capabilities,” said Kevin Perhamus, President and Chief Executive Officer of Arxis.

 

“Operationally, revenue increased 25% year-over-year, including 21% organic growth, reflecting broad-based demand across our end markets, new business wins, favorable pricing realization, and continued momentum across both of our segments. Adjusted EBITDA(1) increased 38% year-over-year to $211 million, while Adjusted EBITDA margin(1) expanded 390 basis points to 42.2%. Margin expansion reflected the benefits of volume growth, disciplined pricing execution, ongoing productivity initiatives, and the operating leverage of our business model.”

 

“Our focus continues to be supporting our customers, investing in new business opportunities, expanding our content on existing and next-generation platforms, integrating acquired businesses, and executing our long-term value creation strategy. Given our strong first-half performance and improved visibility into the second half of the year, supported by secured purchase orders, completed acquisitions, and continued strength in underlying demand, we are raising our full-year guidance.”

 

 

 

 

 

 

 

(1) Additional detail on non-GAAP financial measures, including reconciliations, is provided in the appendix.

 

1

 


 

Second Quarter 2026 Unaudited Condensed Consolidated Results

 

 

Three Months Ended June 30,

 

(Dollars in millions, except per share amounts)

 

2026

 

2025

 

Change

Revenue

 

$

501

 

 

$

400

 

 

 

25

%

Net loss

 

$

(5

)

 

$

(29

)

 

NM

 

Net loss margin

 

 

(1.0

)%

 

 

(7.3

)%

 

NM

 

Diluted loss per share

 

$

(0.01

)

 

N/A

 

 

N/A

 

Adjusted EBITDA(1)

 

$

211

 

 

$

154

 

 

 

38

%

Adjusted EBITDA margin(1)

 

 

42.2

%

 

 

38.4

%

 

390 bps

 

Adjusted Net Income(1)

 

$

113

 

 

$

14

 

 

 

726

%

Adjusted Diluted Earnings Per Share(1)

 

$

0.28

 

 

N/A

 

 

N/A

 

Net cash provided by operating activities

 

$

138

 

 

$

48

 

 

 

188

%

Free Cash Flow(1)

 

$

127

 

 

$

35

 

 

 

261

%

 

NM = not meaningful due to the small prior-year comparison base.

 

Revenue of $501 million increased 25% year-over-year, including 21% organic growth, reflecting broad-based strength across all of our key end markets. Both the Electronic Components and Mechanical Components segments delivered growth during the quarter, driven by strong demand in Defense & Space and continued favorable trends in Commercial Aerospace and Industrial Technology.

 

Net loss of ($5) million improved by $24 million year-over-year, with net loss margin of -1.0% compared to -7.3% in the prior-year period. The year-over-year improvement reflected stronger operating performance, while net income was offset by share-based compensation expense associated with the Company's initial public offering.

 

Adjusted EBITDA(1) increased 38% year-over-year to $211 million, while Adjusted EBITDA margin(1) expanded 390 basis points to 42.2%. The margin expansion was driven by strong operating leverage on higher volumes, favorable pricing realization, and continued execution of productivity and cost management initiatives.

 

Recent Acquisition Activity

 

As previously announced, Arxis completed the acquisition of MagCanica, LLC ("MagCanica") on June 1, 2026. MagCanica is a designer and manufacturer of non-contact, high-precision torque sensors that operate under extreme conditions.

 

Separately, on June 2, 2026, Arxis entered into a definitive agreement to acquire Omnetics Connector Corporation ("Omnetics"), a leading designer and manufacturer of proprietary high-reliability Micro-D-Sub and Nano-D-Sub connectors and interconnect systems used in critical defense and space, commercial aerospace, and medical applications. The transaction remains subject to customary regulatory approvals and closing conditions and is expected to close during the third quarter of 2026.

 

Subsequent to quarter end, on July 29, 2026, Arxis completed the acquisition of Blue Line Engineering Co. ("Blue Line"), a designer and manufacturer of high-reliability precision position sensors and motion-control systems.

Balance Sheet Update

 

During the quarter, Arxis completed a repricing of its term loan facility, reducing borrowing costs while preserving balance sheet flexibility.

 

The transaction is expected to generate approximately $5 million of annualized cash interest savings and further enhance free cash flow conversion. Following the repricing, Arxis ended the quarter with net leverage(1) of 1.8x, providing substantial capacity to continue executing its acquisition strategy.

 

(1) Additional detail on non-GAAP financial measures, including reconciliations, is provided in the appendix.

 

2

 


 

Full-Year 2026 Guidance

 

 

Raising Full-Year Guidance

(Dollars in millions)

 

Current(3)

 

Prior

 

Change at Midpoint

Revenue

 

$1,960 to $1,980

 

$1,860 to $1,880

 

+$100

Adjusted EBITDA(2)

 

$790 to $800

 

$720 to $730

 

+$70

Adjusted EBITDA margin(2)

 

~40.4%

 

~38.8%

 

+160 bps

 

(2)
Arxis has not reconciled its full-year 2026 guidance related to Adjusted EBITDA and Adjusted EBITDA margin to its most directly comparable forward looking GAAP financial measure because such information is not available, and management cannot reliably predict all of the necessary components of such GAAP measure without unreasonable effort or expense.
(3)
Includes Micro-Tronics, MagCanica, and Blue Line acquisitions.

 

Conference Call and Webcast Information

Arxis will host an investor conference call to discuss its second quarter results at 9:00 a.m. ET on Thursday, July 30, 2026. A live webcast of the call, along with related presentation materials, will be available on the News & Events section of the Company’s website at https://ir.arxis.com. A replay of the webcast will be available for 30 days following the call.

 

About Arxis

Arxis is a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components for aerospace and defense, medical technology, and specialized industrial markets. Leveraging significant intellectual property and world-class engineering and operational capabilities, Arxis designs and delivers innovative solutions that address its customers' most complex performance needs. Arxis is a portfolio company of Arcline Investment Management. For more information, visit www.arxis.com.

About Arcline Investment Management

Arcline Investment Management is a private investment firm with over $30 billion in assets under management. Arcline seeks to build the next generation of Industrial Compounders – market-leading, mission-critical industrial platforms designed to consistently compound earnings over decades. For more information, visit www.arcline.com.

Non-GAAP Financial Measures

This press release includes certain “non-GAAP financial measures,” which are financial measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), including Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income, Adjusted Diluted Earnings Per Share, Free Cash Flow, and Net Leverage. We use these non-GAAP financial measures to evaluate our business operations.

The non-GAAP financial measures presented in this press release are supplemental measures of our performance and our liquidity that we believe help investors understand our financial condition and operating results and assess our future prospects. We believe that presenting these non-GAAP financial measures, in addition to the corresponding U.S. GAAP financial measures, are important supplemental measures that exclude non-cash or other items that may not be indicative of or are unrelated to our core operating results and the overall health of our company. We believe that these non-GAAP financial measures provide investors greater transparency to the information used by management for its operational decision-making and allow investors to see our results “through the eyes of management.” We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance. When read in conjunction with our U.S. GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as one basis for financial, operational, and planning decisions. Finally, these measures are often used by analysts and other interested parties to evaluate companies in our industry.

We define Adjusted EBITDA as net income (loss) before interest expense, net, income tax expense (benefit), and depreciation and amortization, further adjusted for certain non-cash items that we may record each period, as well as non-recurring items such as transaction costs and other deal related expenses, acquisition and integration costs, restructuring costs, share-based compensation expense, and other income and expense adjustments that are non-recurring, non-operational, or not reflective of core operating performance, when applicable. We define Adjusted EBITDA margin as Adjusted EBITDA divided by Revenue. We believe that Adjusted EBITDA and Adjusted EBITDA margin are important metrics for management and investors as they remove the impact of

 

3

 


 

items that we do not believe are indicative of our core operating results or the overall health of our company and allows for consistent comparison of our operating results over time and relative to our peers.

 

We define Adjusted Net Income as net income (loss) adjusted to exclude amortization of intangible assets, acquisition and integration costs, restructuring costs, transaction and other deal related expenses, share-based compensation expense, and other items that management does not consider indicative of the Company’s core operating performance, together with the related income tax effects of these adjustments. Adjusted Diluted Earnings Per Share is calculated by dividing Adjusted Net Income attributable to common stockholders by the diluted weighted-average number of common shares outstanding during the applicable period. We believe Adjusted Net Income and Adjusted Diluted Earnings Per Share provide investors with useful supplemental measures for evaluating the Company’s underlying operating performance and comparing results across periods.

 

We define Free Cash Flow as net cash provided by (used in) operating activities less capital expenditures. We believe this measure allows management and investors to evaluate the capacity of our operations to generate cash that is available to service debt and make strategic investments and acquisitions.

 

We define Net Leverage as net debt divided by Adjusted EBITDA for the trailing twelve-month period. Net debt is calculated as total debt, less cash and cash equivalents. We believe this measure allows us to evaluate our capital structure, indebtedness, and ability to service debt.

Management recognizes that these non-GAAP financial measures have limitations, including that they may be calculated differently by other companies or may be used under different circumstances or for different purposes, thereby affecting their comparability from company to company. To compensate for these and the other limitations discussed below, management does not consider these measures in isolation from or as alternatives to the comparable financial measures determined in accordance with U.S. GAAP. The reconciliations to their most directly comparable U.S. GAAP financial measures follow. Readers should review the reconciliations below and should not rely on any single financial measure to evaluate our business. Unless otherwise noted, tables are presented in U.S. dollars in thousands. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented in this report are calculated from the underlying numbers in thousands.

 

FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “guidance”, “will”, “may,” and negatives or derivatives of these or similar expressions.

These forward-looking statements reflect our current expectations, are based on judgments and assumptions, are inherently uncertain and are subject to risks, uncertainties, and other factors, which could cause our actual results, performance, or achievements to differ materially from current expectations. Some of the risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by forward-looking statements include, but are not limited to: the concentration of our business on the aerospace and defense industries; the unique business risks of supplying products to companies contracting with the U.S. government; the significant competition that we face; our industry’s rapid change; any decline or lower-than-anticipated growth of the markets into which we sell our products and services; cost overruns; the availability and pricing of certain components and raw materials from suppliers; inflation; our products may not operate as intended; our decentralized organizational structure; our indebtedness and the restrictive covenants under the agreements governing our indebtedness; our ability to comply with the extensive governmental regulation to which we are subject; our ability to maintain our government or industry approvals; product liability lawsuits and product recalls; our ability to obtain, maintain, protect and enforce our intellectual property and proprietary rights on which our business depends; our ability to realize the anticipated benefits from our recent reorganization; and the significant transaction costs that we have incurred and expect to continue to incur in connection with our recent reorganization and as a public company.

 

These or other uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements, and these and other factors are more fully discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company’s filings with the Securities and Exchange Commission, including those set forth in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. We do not undertake any obligation to update or revise our forward-looking statements except as may be required by law or regulation. This press release also includes certain forward-looking projected financial information that is based on current estimates and forecasts. Actual results could differ materially.

 

 

4

 


 

Contact:

Investor Relations

ir@arxis.com

+1 860-243-7100 (Select 1 for Arxis)

 

5

 


 

Table 1: Condensed Consolidated Statements of Operations

(Unaudited, in thousands, except share and per share amounts)

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

 

2025

 

Revenue

 

$

500,728

 

 

$

400,444

 

 

$

959,586

 

 

 

$

780,523

 

Cost of revenue

 

 

238,127

 

 

 

202,830

 

 

 

462,142

 

 

 

 

419,998

 

Gross profit

 

 

262,601

 

 

 

197,614

 

 

 

497,444

 

 

 

 

360,525

 

Selling, general and administrative expenses

 

 

193,633

 

 

 

80,578

 

 

 

281,950

 

 

 

 

149,204

 

Amortization of intangible assets

 

 

36,284

 

 

 

34,183

 

 

 

72,307

 

 

 

 

68,263

 

Operating income

 

 

32,684

 

 

 

82,853

 

 

 

143,187

 

 

 

 

143,058

 

Interest expense, net

 

 

39,427

 

 

 

57,356

 

 

 

83,385

 

 

 

 

125,616

 

Other income, net

 

 

(5,329

)

 

 

(3,589

)

 

 

(7,796

)

 

 

 

(4,818

)

Net income (loss) before income taxes

 

 

(1,414

)

 

 

29,086

 

 

 

67,598

 

 

 

 

22,260

 

Income tax expense

 

 

3,495

 

 

 

58,342

 

 

 

19,198

 

 

 

 

55,840

 

Net income (loss)

 

$

(4,909

)

 

$

(29,256

)

 

$

48,400

 

 

 

$

(33,580

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share, basic and diluted

 

$

(0.01

)

 

N/A

 

 

$

(0.01

)

(1)

 

N/A

 

Weighted-average common shares outstanding, basic and diluted

 

 

401,813,695

 

(2)

N/A

 

 

 

401,813,695

 

(2)

 

N/A

 

 

(1)
Only represents basic and diluted net loss per share for the three months ended June 30, 2026, which represents the period during which the Company had common stock outstanding.
(2)
Weighted-average common shares outstanding is calculated based on the shares issued in connection with the Reorganization reflected as outstanding starting on April 1, 2026 and the shares issued in the IPO starting on April 16, 2026.

 

6

 


 

Table 2: Condensed Consolidated Balance Sheets

(Unaudited, in thousands, except share amounts)

 

 

June 30, 2026

 

 

December 31, 2025

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

494,693

 

 

$

250,303

 

Accounts receivable, net

 

 

273,366

 

 

 

216,936

 

Contract assets

 

 

81,441

 

 

 

67,780

 

Inventories

 

 

337,700

 

 

 

315,604

 

Prepaid expenses and other current assets

 

 

48,123

 

 

 

57,058

 

Total current assets

 

 

1,235,323

 

 

 

907,681

 

Property, plant and equipment, net

 

 

405,485

 

 

 

397,929

 

Intangible assets, net

 

 

2,448,201

 

 

 

2,429,879

 

Goodwill

 

 

2,799,108

 

 

 

2,745,351

 

Operating lease right-of-use assets, net

 

 

64,951

 

 

 

64,651

 

Other assets

 

 

53,584

 

 

 

50,943

 

Total assets

 

$

7,006,652

 

 

$

6,596,434

 

 

 

 

 

 

 

Liabilities and stockholders' and members' equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

67,094

 

 

$

56,467

 

Contract liabilities, current

 

 

23,176

 

 

 

30,027

 

Operating lease liabilities, current

 

 

11,091

 

 

 

10,584

 

Debt, current

 

 

119

 

 

 

26,853

 

Accrued expenses and other current liabilities

 

 

135,502

 

 

 

163,230

 

Total current liabilities

 

 

236,982

 

 

 

287,161

 

Debt, noncurrent

 

 

1,718,018

 

 

 

2,606,459

 

Contract liabilities, noncurrent

 

 

1,270

 

 

 

1,414

 

Operating lease liabilities, noncurrent

 

 

54,142

 

 

 

53,798

 

Deferred tax liabilities

 

 

383,137

 

 

 

384,420

 

Other long-term liabilities

 

 

145,545

 

 

 

139,124

 

Total liabilities

 

 

2,539,094

 

 

 

3,472,376

 

 

 

 

 

 

 

Class A Common Stock, $0.01 par value, 3,500,000,000 shares authorized; 77,712,735 issued; 76,797,587 outstanding as of June 30, 2026

 

 

777

 

 

 

 

Class B Common Stock, $0.01 par value, 3,500,000,000 shares authorized; 340,676,783 issued and outstanding as of June 30, 2026

 

 

3,407

 

 

 

 

Class C Common Stock, $0.01 par value, 500,000,000 shares authorized; no shares issued or outstanding as of June 30, 2026

 

 

 

 

 

 

Convertible Common Stock, $0.01 par value, 1 share authorized; 1 share issued and outstanding as of June 30, 2026

 

 

 

 

 

 

Preferred stock, $0.01 par value, 500,000,000 shares authorized; no shares issued or outstanding as of June 30, 2026

 

 

 

 

 

 

Additional paid-in capital

 

 

4,512,250

 

 

 

 

Accumulated deficit

 

 

(16,112

)

 

 

 

Accumulated other comprehensive income

 

 

1,875

 

 

 

 

Treasury stock, at cost, 915,148 shares

 

 

(34,639

)

 

 

 

Members’ equity

 

 

 

 

 

3,124,058

 

Total stockholders’ and members' equity

 

 

4,467,558

 

 

 

3,124,058

 

Total liabilities and stockholders' and members' equity

 

$

7,006,652

 

 

$

6,596,434

 

 

 

7

 


 

Table 3: Condensed Consolidated Statements of Cash Flows

(Unaudited, in thousands)

 

 

Six Months Ended June 30,

 

 

2026

 

 

2025

 

Cash flow from operating activities:

 

 

 

 

 

 

Net income (loss)

 

$

48,400

 

 

$

(33,580

)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

103,556

 

 

 

98,093

 

Amortization of deferred financing cost and accretion of paid-in-kind interest

 

 

2,576

 

 

 

3,190

 

Amortization of inventory fair value adjustment

 

 

1,437

 

 

 

18,177

 

Loss (gain) on sale and disposal of assets

 

 

(101

)

 

 

9,958

 

Share-based compensation expense

 

 

102,064

 

 

 

4,536

 

Interest rate hedges change in fair value

 

 

(4,637

)

 

 

5,770

 

Deferred income taxes

 

 

(1,004

)

 

 

(2,143

)

Loss on extinguishment of debt

 

 

11,447

 

 

 

15,535

 

Changes in operating assets and liabilities, net of business acquisitions:

 

 

 

 

 

 

Accounts receivable

 

 

(52,034

)

 

 

(27,301

)

Inventories

 

 

(17,859

)

 

 

(32,954

)

Prepaid expenses and other current assets

 

 

9,096

 

 

 

(5,112

)

Accounts payable

 

 

11,119

 

 

 

(4,393

)

Accrued expenses and other current liabilities

 

 

(26,143

)

 

 

17,732

 

Contract assets and liabilities

 

 

(20,688

)

 

 

(6,504

)

All other assets and liabilities

 

 

7,502

 

 

 

7,466

 

Other operating activities, net

 

 

(377

)

 

 

135

 

Net cash provided by (used in) operating activities

 

 

174,354

 

 

 

68,605

 

Cash flow from investing activities:

 

 

 

 

 

 

Capital expenditures

 

 

(22,290

)

 

 

(21,395

)

Proceeds from sale and disposal of assets, net of cash sold

 

 

147

 

 

 

2,187

 

Acquisition of businesses, net of cash acquired

 

 

(185,817

)

 

 

(152,639

)

Net cash provided by (used in) investing activities

 

 

(207,960

)

 

 

(171,847

)

Cash flow from financing activities:

 

 

 

 

 

 

Net proceeds from issuance of common stock

 

 

1,227,753

 

 

 

 

Payments for taxes related to net share settlement of equity awards

 

 

(34,639

)

 

 

 

Proceeds from issuance of debt

 

 

25,000

 

 

 

2,784,000

 

Repayments of debt

 

 

(952,809

)

 

 

(2,598,348

)

Payments of debt financing fees

 

 

 

 

 

(38,907

)

Issuance of related party notes receivable

 

 

 

 

 

(3,000

)

Settlement of related party notes receivable(1)

 

 

5,426

 

 

 

1,500

 

Repayments of related party payables

 

 

 

 

 

(7,000

)

Distributions

 

 

(332

)

 

 

(351,119

)

Contributions

 

 

11,344

 

 

 

385,000

 

Other financing activities, net

 

 

(2,519

)

 

 

(845

)

Net cash provided by (used in) financing activities

 

 

279,224

 

 

 

171,281

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(1,228

)

 

 

(8,338

)

Net increase (decrease) in cash and cash equivalents

 

 

244,390

 

 

 

59,701

 

Cash and cash equivalents, beginning of the period

 

 

250,303

 

 

 

110,838

 

Cash and cash equivalents, end of the period

 

$

494,693

 

 

$

170,539

 

 

 

8

 


 

Table 4: Reconciliation of Net income (loss) to Adjusted EBITDA and Adjusted EBITDA Margin

(Unaudited, in thousands except for percentages)

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net income (loss)

 

$

(4,909

)

 

$

(29,256

)

 

$

48,400

 

 

$

(33,580

)

Interest expense, net

 

 

39,427

 

 

 

57,356

 

 

 

83,385

 

 

 

125,616

 

Income tax expense (benefit)

 

 

3,495

 

 

 

58,342

 

 

 

19,198

 

 

 

55,840

 

Depreciation and amortization

 

 

52,028

 

 

 

49,099

 

 

 

103,556

 

 

 

98,093

 

Acquisition and integration costs(1)

 

 

715

 

 

 

1,214

 

 

 

1,437

 

 

 

19,963

 

Restructuring costs(2)

 

 

 

 

 

738

 

 

 

270

 

 

 

2,475

 

Transaction and other deal related expenses(3)

 

 

1,819

 

 

 

4,074

 

 

 

9,044

 

 

 

4,955

 

Share-based compensation expense(4)

 

 

107,111

 

 

 

2,206

 

 

 

109,591

 

 

 

4,536

 

Other non-recurring adjustments(5)

 

 

11,812

 

 

 

9,901

 

 

 

11,812

 

 

 

9,901

 

Adjusted EBITDA

 

$

211,498

 

 

$

153,674

 

 

$

386,693

 

 

$

287,799

 

Revenue

 

$

500,728

 

 

$

400,444

 

 

$

959,586

 

 

$

780,523

 

Adjusted EBITDA Margin

 

 

42.2

%

 

 

38.4

%

 

 

40.3

%

 

 

36.9

%

 

(1)
Represents costs incurred to integrate acquired businesses and product lines into our operations, facility relocation costs, rebranding, system implementation costs and employee expenses related to acquisitions. This also includes amortization expenses of inventory step-up recorded in connection with purchase accounting of acquired businesses.
(2)
Represents severance, facility consolidation/closure costs and other charges associated with restructuring programs.
(3)
Represents third-party transaction-related costs for acquisitions comprising deal fees, legal, financial and tax due diligence expenses and valuation costs that are required to be expensed as incurred.
(4)
Represents the compensation expense under our share-based plans and deferred compensation plans. Includes $7.5 million for employer taxes related to vested RSUs for the three and six months ended June 30, 2026.
(5)
Represents other income and expense adjustments that are non-recurring, non-operational or not reflective of core performance, such as loss on disposal of assets, commercial commitments or legal settlements, income from transition services agreements and non-operational pension impacts. Includes $13.3 million of expense related to the Convertible-Related Tax Receivable Agreement for the three and six months ended June 30, 2026.

 

9

 


 

Table 5: Reconciliation of Net income (loss) to Adjusted Net Income and Adjusted Diluted Earnings Per Share

(Unaudited, in thousands except share and per share amounts)

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net income (loss)

 

$

(4,909

)

 

$

(29,256

)

 

$

48,400

 

 

$

(33,580

)

Amortization of intangible assets

 

 

36,284

 

 

 

34,183

 

 

 

72,307

 

 

 

68,263

 

Acquisition and integration costs

 

 

715

 

 

 

1,214

 

 

 

1,437

 

 

 

19,963

 

Restructuring costs

 

 

 

 

 

738

 

 

 

270

 

 

 

2,475

 

Transaction and other deal related expenses

 

 

1,819

 

 

 

4,074

 

 

 

9,044

 

 

 

4,955

 

Share-based compensation expense

 

 

107,111

 

 

 

2,206

 

 

 

109,591

 

 

 

4,536

 

Other non-recurring adjustments

 

 

11,812

 

 

 

9,901

 

 

 

11,812

 

 

 

9,901

 

Tax adjustment(1)

 

 

(39,625

)

 

 

(9,359

)

 

 

(51,361

)

 

 

(19,696

)

Adjusted Net Income

 

$

113,207

 

 

$

13,701

 

 

$

201,500

 

 

$

56,817

 

Adjusted Net Income Post-IPO

 

$

113,207

 

 

N/A

 

 

$

113,207

 

(2)

 

N/A

 

Less: undistributed income allocated to participating securities

 

 

 

 

N/A

 

 

 

 

(2)

 

N/A

 

Adjusted Net Income attributable to common stockholders

 

$

113,207

 

 

N/A

 

 

$

113,207

 

 

N/A

 

Net loss per common share, basic and diluted

 

$

(0.01

)

 

N/A

 

 

$

(0.01

)

(2)

 

N/A

 

Adjusted Net Income per common share, diluted(3)

 

$

0.28

 

 

N/A

 

 

$

0.28

 

(2)

 

N/A

 

Adjusted weighted-average common shares outstanding, diluted(3)

 

 

407,505,928

 

(4)

N/A

 

 

 

407,505,928

 

(4)

N/A

 

 

(1)
The tax adjustment represents the income tax effect of the adjustments at the applicable effective tax rate. Share-based compensation expense is excluded from Adjusted Net Income, and therefore, we have excluded the impact that share-based compensation expense has on the effective tax rate for determining Adjusted Net Income.
(2)
Only represents Adjusted Net Income, undistributed income allocated to participating securities, if any, Adjusted Net Income attributable to common stockholders, net loss per common share, basic and diluted, and Adjusted Net Income per common share, diluted for the three months ended June 30, 2026, which represents the period during which the Company had common stock outstanding.
(3)
Adjusted Net Income per common share is calculated as Adjusted Net Income attributable to common stockholders divided by the adjusted weighted-average number of common shares outstanding, diluted during the period (which represents the weighted average common shares outstanding plus the effect of dilutive common share equivalents based on the most dilutive result of the if-converted and two-class methods).
(4)
Adjusted weighted-average common shares outstanding is calculated based on the shares issued in connection with the Reorganization reflected as outstanding starting on April 1, 2026 and the shares issued in the IPO starting on April 16, 2026.

 

10

 


 

Table 6: Reconciliation of Net cash provided by operating activities to Free Cash Flow

(Unaudited, in thousands)

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net cash provided by operating activities

 

$

137,885

 

 

$

47,843

 

 

$

174,354

 

 

$

68,605

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

Capital expenditures

 

 

(10,587

)

 

 

(12,600

)

 

 

(22,290

)

 

 

(21,395

)

Free Cash Flow

 

$

127,298

 

 

$

35,244

 

 

$

152,064

 

 

$

47,210

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

11

 


 

Table 7: Net Leverage Reconciliation

(Unaudited, in thousands except for multiples)

 

 

 

June 30, 2026

 

 

March 31, 2026

 

 

December 31, 2025

 

Total debt

 

$

1,718,137

 

 

$

2,652,495

 

 

$

2,633,312

 

Add: Unamortized deferred financing costs

 

 

15,523

 

 

 

27,225

 

 

 

28,159

 

Less: Cash and cash equivalents

 

 

(494,693

)

 

 

(238,918

)

 

 

(250,303

)

Total net debt

 

$

1,238,967

 

 

$

2,440,802

 

 

$

2,411,168

 

Net income(1)

 

 

127,969

 

 

 

103,622

 

 

 

45,989

 

Adjusted EBITDA(2)

 

 

670,198

 

 

 

612,374

 

 

 

571,304

 

Total debt to net income

 

13.4x

 

 

25.6x

 

 

57.3x

 

Net Leverage

 

1.8x

 

 

4.0x

 

 

4.2x

 

 

(1)
Represents Net income for the trailing twelve-month period. Net income for the trailing twelve-month period ended June 30, 2026, is calculated as Net income for the year ended December 31, 2025, less Net income (loss) for the six months ended June 30, 2025, plus Net income for the six months ended June 30, 2026.
(2)
Represents Adjusted EBITDA for the trailing twelve-month period. Adjusted EBITDA for the trailing twelve-month period ended June 30, 2026, is calculated as Adjusted EBITDA for the year ended December 31, 2025, less Adjusted EBITDA for the six months ended June 30, 2025, plus Adjusted EBITDA for the six months ended June 30, 2026.

 

12

 


Filing Exhibits & Attachments

2 documents